BD Rx gains FDA nod for generic injectable vomiting drug

04/23/2013 | Drug Store News

BD Rx received federal approval for its metoclopramide injectable drug to address vomiting. The drug is the second product to be approved among the BD Simplist line of pre-filled generic injectables, designed to reduce the number of steps needed before administration.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI